NCT03794323View on ClinicalTrials.gov

A Study in Healthy Men to Find Out How Well Different Doses of BI 764122 Are Tolerated and Whether Food Affects the Amount of BI 764122 in the Blood

PHASE1CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

January 30, 2019

Primary Completion Date

August 12, 2019

Study Completion Date

August 12, 2019

Conditions
Healthy
Interventions
DRUG

BI 764122

Tablet

DRUG

Placebo

Tablet

Trial Locations (1)

2650

SGS Life Science Services - Clinical Research, Edegem

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY